摘要
Cancer is recognized as a leading cause of deaths nowadays,accounting for 10 million annual deaths worldwide and resulting in heavy health and economic burdens[1].Reducing cancer incidence through precision prevention is thus of great scientific and clinical value.Gastric cancer(GC)is one of the most common cancers in China.Pathologically,the onset of GC,especially the intestinal-type ones,would usually suffer a series of premalignant lesions,including atrophic gastritis,intestinal metaplasia,and low-grade dysplasia(LGD),which is known as the process of gastritis-induced tumorigenesis(GIGT)[2].Epidemiological studies have shown that GIGT has exhibited the characteristics of longterm and low-probability,that is,only a small number of gastritis patients would develop into GC after a long period.Therefore,it has become the key challenge for GC precision prevention that how to uncover the biological mechanism underlying GIGT,followed by accurately identifying the critical time point at which effective diagnosis and treatment strategies could be developed to prevent GC.Of note,this is also a common challenge for the precision prevention of other cancer types,such as liver and colon cancers.
作者
张鹏
汪博洋
李梢
Peng Zhang;Boyang Wang;Shao Li(Institute of TCM-X/MOE Key Laboratory of Bioinformatics,Bioinformatics Division,BNRist/Department of Automation,Tsinghua University,Beijing 100084,China)
基金
supported by the National Natural Science Foundation of China(T2341008,62061160369,and 81225025).